Table: SymBio Pharmaceuticals -2023 group results

SymBio Pharmaceuticals

08/02/2024 06:45

Feb 8 (Reuters)- 
          SymBio Pharmaceuticals Limited 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                   Year ended      Year ended        Year to        NEXT   
                Dec 31, 2023    Dec 31, 2022    Dec 31, 2024      YEAR     
                   LATEST         YEAR-AGO         COMPANY       COMPANY   
                   RESULTS         RESULTS        FORECAST     H1 FORECAST 
  Sales             5.59            10.01           3.64                   
                 (-44.1 pct)                     (-34.9 pct)               
  Operating     loss 811 mln         1.96         loss 2.84                
  Recurring     loss 736 mln         2.00         loss 2.87                
  Net
  Net             loss 1.96          1.18         loss 2.87                
  EPS          loss 49.19 yen     30.20 yen    loss 71.93 yen              
  EPS Diluted                     29.77 yen                                
  Ann Div            NIL             NIL             NIL                   
  -Q2 Div            NIL             NIL             NIL                   
  -Q4 Div            NIL             NIL             NIL                   
  
  NOTE - SymBio Pharmaceuticals Limited.
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4582.T